Please assess the completion status of the following clinical trial:

Trial Title: Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients \>= 18 years old~* Source of infection~* Two or more of systemic inflammatory response syndrome criteria~* Systolic blood pressure \< 90 mmHg after a fluid bolus OR lactate \>= 4 mmol/L~* A central line has been placed for CVP/ScvO2 monitoring~Exclusion Criteria:~* Pregnancy~* Acute stroke~* Acute cardiogenic pulmonary edema~* Status asthmaticus~* Unstable cardiac dysrhythmia~* Active hemorrhage~* Acute seizure~* Drug overdose~* Trauma~* Requiring immediate surgery~* Do-not-resuscitate status

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MiCHO (Type: EXPERIMENTAL): A 6-hour resuscitation protocol utilizing the esophageal Doppler monitoring (EDM)
- EGDT (Type: ACTIVE_COMPARATOR): A 6-hour resuscitation protocol utilizing CVP/ScvO2

Based on this trial design, predict the completion outcome and termination type (if applicable).